Can I buy Keytruda Pembrolizumab for 140,000 and use it for two years?

Keytruda is the brand name of Pembrolizumab (Pembrolizumab) which is marketed in China. This immune checkpoint inhibitor is an immunotherapy used to treat various cancers. It inhibits and kills cancer immune cells. In some patients, these drugs can lead to long-term remission, but these activated immune cells can also damage healthy tissue, causing side effects.

Pembrolizumab can be used alone or with other anticancer drugs and is given by intravenous drip (intravenous infusion). Pembrolizumab may be given at 200 mg/kg every 3 weeks or 400 mg every 6 weeks, with the pembrolizumab dose for children and adolescents starting at 2 mg/kg, up to 200 mg. For most types of cancer, pembrolizumab is usually given for 2 years.

Pembrolizumab original drug, specifications100mg/4ml per box may be priced at about 15,000 RMB, which is marketed in China. This drug is a strictly controlled drug and has not yet been included in the medical insurance. Patients need to pay for it at their own expense. The price may cost about 200,000 RMB in about two years, which is expensive. Pembrolizumab The price of the European version of the original drug 100mg/4ml per box may be around RMB 25,000, and the price of the Turkish version of 100mg/4ml per box may be around 10,000 RMB (the price may fluctuate due to the exchange rate). The ingredients of the original drugs at home and abroad are basically the same, and they are expensive. There are currently no generic versions of Pembrolizumab available overseas.